Reducing the Risk of a Second Cancer After Treatment

Nearly one in five cancers diagnosed today occurs in a person who has had cancer before. That statistic is often misread. It describes the makeup of new diagnoses in a country with more than seventeen million cancer survivors and improving survival. It does not describe your chance of facing a second cancer.

For most adults treated with modern regimens, the added risk from treatment itself is small in absolute terms. It is consistently outweighed by the benefit of treating the cancer you had. Radiation fields have narrowed. Doses have been refined. Some drug classes are used more sparingly than in past decades. All of that happened because this risk is known and taken seriously.

What follows is not a reason for alarm. It is a map of where the risk comes from, and which parts of it you can act on.

Treatment. Radiation damages DNA in healthy tissue near the target. Certain chemotherapies do the same throughout the body. The pattern is fairly predictable. Alkylating agents such as cyclophosphamide and busulfan carry a small risk of myelodysplastic syndrome and acute myeloid leukaemia. These usually appear five to ten years afterwards. Topoisomerase II inhibitors carry a similar risk on a shorter clock, often one to three years. Radiation-related solid tumors — breast, lung, thyroid, sarcomas — generally take ten years or more. They tend to arise at or near the edge of the treated field. Targeted therapies and immunotherapies appear to carry lower risk, though it is less well mapped.

A few groups carry much higher risk. That includes people treated as children, and people who had chest radiation at a young age, such as for Hodgkin lymphoma. Chest radiation before around age 30 raises later breast cancer risk enough to warrant its own screening, often including MRI. It starts eight years after radiation, or at age 25.

Shared risk factors. This is the part most often overlooked. Whatever helped cause the first cancer often has not gone away: tobacco, alcohol, excess body weight, inactivity, sun exposure, HPV infection. Take someone treated for a smoking-related head and neck cancer who keeps smoking. Their risk of a second smoking-related cancer is high, and it is larger than anything the treatment added.

Inherited susceptibility. Conditions such as BRCA1, BRCA2, and Lynch syndrome raise the risk of several distinct cancers. If one is present, a second cancer may reflect that condition rather than the treatment. Surveillance then changes for you, and for your relatives too.

Most of the ground you can change sits in that second category.

Stopping tobacco is the single biggest lever if it applies to you. It still helps after a cancer diagnosis. Limiting alcohol matters for cancers of the mouth, throat, esophagus, liver, colon, and breast. Reaching a healthy weight and staying active addresses a set of cancers linked to excess body fat. The World Cancer Research Fund's prevention recommendations apply to survivors as well. Sun protection matters too, above all after radiation or a stem cell transplant, since both raise skin cancer risk. And ask about HPV vaccination if you are within the eligible age range.

Also stay on ordinary population screening. This is a real and common gap. Frequent oncology appointments focused on your original cancer can quietly crowd out mammography, colonoscopy, and cervical screening. Being under specialist care is not the same as being screened.

A survivorship care plan has two parts. One is a treatment summary recording exactly what you received: specific drugs, cumulative doses, radiation fields and doses. The other is a follow-up plan setting out what should be checked, how often, and by whom.

The treatment summary matters more than it looks. Ten or twenty years from now, a new clinician will not know your history. They will need to know whether you had anthracyclines. They will need to know where the radiation field sat and what dose it delivered. That information is hard to reconstruct later. If you do not have it in writing, it is reasonable to ask for it.

Second cancers often announce themselves like any other cancer: unexplained weight loss, persistent fatigue out of keeping with your recovery, unusual bruising or bleeding, a new lump, a change in bowel or bladder habit, a cough or hoarseness lasting more than three weeks, a changing skin lesion.

A new symptom is not evidence that anything has gone wrong. It is a reason to be evaluated rather than to wait. After treatment, you have both a team who knows you and a low threshold for looking.

• NCI Division of Cancer Epidemiology and Genetics: Second primary cancers among cancer survivors
• NCI: Follow-up care after cancer treatment
• World Cancer Research Fund: Cancer prevention recommendations